MUTANTS WHICH PRODUCE A POTENTIATOR OF BACILLUS PESTICIDAL ACTIVITY

Abstract: This invention is directed to Bacillus mutants which produce a factor which potentiates the pesticidal activity of a Bacillus related pesticide, a chemical pesticide and/or a virus with pesticidal properties.

Description: MUTANTS WHICH PRODUCE A POTENTIATOR OF BACILLUS PESTICIDAL ACTIVITY This application is a continuation-in-part application of application serial no. 08/146,852, filed November 3, 1993, which is a continuation-in-part of application serial no. 08/095,240, filed July 20, 1993, which is a continuation-in-part of applcation serial no. 07/990,202, filed December 14, 1992, which is a continuation-in-part of application serial no. 07/971,786, filed November 5, 1992. 1. FIELD OF THE INVENTION The invention is related to a mutant Bacillus strain which produces a factor which potentiates the pesticidal activity of a Bacillus related pesticide, a chemical pesticide and/or a virus with pesticidal properties, in which such a factor is obtained in larger amounts or has a greater potentiating activity compared to the parental strain, and methods for producing such mutant strains. The invention also relates to methods for obtaining the factor. 2. BACKGROUND OF THE INVENTION Every year, pests detrimental to agriculture, forestry, and public health cause losses in the millions of dollars. Various strategies have been used to control such pests. One strategy is the use of chemical pesticides with a broad range or spectrum of activity. However, there are a number of disadvantages with using chemical pesticides. Specifically, because of their broad spectrum of activity, these pesticides may destroy non-target organisms such as beneficial insects and parasites of destructive pests. Additionally, chemical pesticides are frequently toxic to animals and humans. Furthermore, targeted pests frequently develop resistance when repeatedly exposed ' to such substances. Another strategy involves the use of biopesticides to control insect, fungal and weed infestations. Biopesticides are naturally occurring pathogens and/or the substances produced by these pathogens. The advantage of using biopesticides is that they are generally less harmful to non-target organisms and the environment as a whole compared to chemical pesticides. 2.1. Bacillus thuringiensis The most widely used biopesticide is Bacillus thuringiensiε . Bacillus thuringiensis is a motile, rod-shaped, gram-positive bacterium that is widely distributed in nature, especially in soil and insect-rich environments. During sporulation, Bacillus thuringiensis produces a parasporal crystal inclusion(s) which is insecticidal upon ingestion to susceptible insect larvae of the orders Lepidop era, Diptera, and Coleoptera. The inclusions may vary in shape, number, and composition. They are comprised of one or more proteins called delta-endotoxins, which may range in size from 27-140 kDa. The insecticidal delta-endotoxins are generally converted by proteases in the larval gut into smaller (truncated) toxic polypeptides, causing midgut destruction, and ultimately, death of the insect (Hδfte and Whiteley, 1989, Microbiological Reviews 53:242-255) . There are several Bacillus thuringiensis strains that are widely used as biopesticides in the forestry, agricultural, and public health areas. Bacillus thuringiensis subsp. kurstaki and Bacillus thuringiensis subsp. aizawai produce delta-endotoxins specific for Lepidoptera. A delta-endotoxin specific for Coleoptera is produced by Bacillus thuringiensis subsp. tenebrionis (Krieg et al . , 1988, U.S. Patent No. 4,766,203). Furthermore, Bacillus thuringiensis subsp. israelensis produces delta-endotoxins specific for Diptera (Goldberg, 1979, U.S. Patent No. 4,166,112). Other Bacillus thuringiensis strains specific for dipteran pests have also been described. A Bacillus thuringiensis isolate has been disclosed which is toxic to Diptera and Lepidoptera (Hodgman et al . , 1993, FEMS Microbiology Letters 114:17-22). SDS polyacrylamide gel electrophoresis of the purified crystal delta-endotoxin from this isolate revealed three protein species which are related to CrylA(b) , CrylB, and CryllA toxins. There has also been disclosed a Bacillus thuringiensis isolate which produces a dipteran-active crystal comprised of proteins with molecular weights of 140, 122, 76, 72, and 38 kDa (Payne, 1994, U.S. Patent No. 5,275,815). EPO 480,762 discloses five 23. t. strains which are each active against dipteran pests; each also have a unique crystal delta- endotoxin pattern. Several Bacillus thuringiensis strains have been described which have pesticidal activity against pests other then Lepidoptera, Coleoptera, and Diptera. Five Bacillus thuringiensis strains have been disclosed which produce delta- endotoxins that are toxic against nematodes (Edwards, Payne, and Soares, 1988, Eur. Pat. Appl. No. 0 303 426 Bl) . There has also been disclosed a Bacillus thuringiensis strain, PS81F, which can be used to treat humans and animals hosting parasitic protozoans (Thompson and Gaertner, 1991, Eur. Pat. Appl. No. 0 461 799 A2) . Several Bacillus thuringiensis isolates have also been disclosed with activity against acaride pests. These isolates produce crystals comprised of proteins with molecular weights in the (wide) range of 35 kDa to 155 kDa (Payne, Cannon, and Bagley, 1992, PCT Application No. WO 92/19106). There have also been disclosed Bacillus thuringiensis strains with activity against pests of the order Hymenoptera (Payne, Kennedy, Randall, Meier, and Uick, 1992, Eur. Pat. Ap l. No. 0 516 306 A2); with activity against pests of the order Hemiptera (Payne and Cannon, 1993, U.S. Patent No. 5,262,159); with activity against fluke pests (Hickle, Sick, Schwab, Narva, and Payne, 1993, U.S. Patent No. U.S. 5,262,399; and with activity against pests of the order Phthiraptera (Payne and Hickle, 1993, U.S. Patent No. 5,273,746). Furthermore, another strain of Bacillus thuringiensis subsp. kurstaki , WB3S-16, isolated from Australian sheep wool clippings, has been disclosed that is toxic to the biting louse Damalinia ovis , a PhtΛira tera pest (Drummond, Miller, and Pinnock, 1992, J. Invert . Path . 60:102-103). The delta-endotoxins are encoded by cry (crystal protein) genes which are generally located on plasmids. The cry genes have been divided into six classes and several subclasses based on relative amino acid homology and pesticidal specificity. The major classes are Lepidoptera-specific (cryJ); Lepidoptera-and Diptera-specific ( cry II) ; Coleoptera-specific (cryJJI); Diptera-specific (cryJV) (Hόfte and Whiteley, 1989, Microbiological Reviews 53:242-255); Coleoptera- and Lepidoptera-specific (referred to as cryV genes by Tailor et al . , 1992, Molecular Microbiology 6:1211-1217) ; and Nematode- specific (referred to as cryV and cryVJ genes by Feitelson et al . , 1992, Bio /Techno logy 10:271-275) . Delta-endotoxins have been produced by recombinant DNA methods. The delta-endotoxins produced by recombinant DNA methods may or may not be in crystal form. Some strains of Bacillus thuringiensis have been shown to produce a heat-stable pesticidal adenine-nucleotide analog, known as β-exotoxin type I or thuringiensin, which is pesticidal alone (Sebesta et al . , in H.D. Burges (ed.), Microbial Control of Pests and Plant Diseases , Academic Press, New York, 1980, pp. 249-281) . β-exotoxin type I has been found in the supernatant of some Bacillus thuringiensis cultures. It has a molecular weight of 701 and is comprised of adenosine, glucose, and allaric acid (Farkas et al . , 1977, Coll . Czechosslovak Chem. Comm . 42:909-929; Luthy et al . , in Kurstak (ed.), Microbial and Viral Pesticides, Marcel Dekker, New York, 1982, pp. 35-72) . Its host range includes, but is not limited to, Musca domestica, Mamestra configurata Walker, Tetranychus urticae, Drosophila melanogaster, and Tetranychus cinnabar inus . The toxicity of β- exotoxin type I is thought to be due to inhibition of DNA- directed RNA polymerase by competition with ATP. It has been shown that β-exotoxin type I is encoded by a cry plasmid in five Bacillus thuringiensis strains (Levinson et al . , 1990, J. Bacteriol . 172:3172-3179). β-exotoxin type I was found to be produced by Bacillus thuringiensis subsp. thuringiensis serotype 1, Bacillus thuringiensis subsp. tolworthi serotype 9, and Bacillus thuringiensis subsp. darmstadiensis serotype 10. Another β-exotoxin classified as β-exotoxin type II has been described (Levinson et al . , 1990, J. Bacteriol . 172:3172-3179). β-exotoxin type II was found to be produced by Bacillus thuringiensis subsp. morrisoni serotype 8ab and is active against Leptinotarsa decemlineata . The structure of β- exotoxin type II is not completely known, but is significantly different from that of β-exotoxin type I in that a pseudouridine moiety is in the place of adenine in which attachment to the ribose ring is at a position that would otherwise be occupied by a proton (Levinson, in Hickle and Finch (eds.), Analytical Chemistry of Bacillus thuringiensis , ACS Symposium Series, Washington, D.C., 1990, pp. 114-136). Furthermore, there is only one signal in the proton NMR spectrum corresponding to the nucleoside base (at 7.95 ppm) , and does not have a ribose-type anomeric protein signal (5.78 ppm). Other water soluble substances that have been isolated from Bacillus thuringiensis include alpha-exotoxin which is toxic against the larvae of Musca domestica (Luthy, 1980, FEMS Microbiol . Lett . 8:1-7); gamma-exotoxins, which are various enzymes including lecithinases, chitinases, and proteases, the toxic effects of which are expressed only in combination with beta-exotoxin or delta-endotoxin (Forsberg et al . , 1976, Bacillus thuringiensis: Its Effects on Environmental Quality, National Research Council of Canada, NRC Associate Committee on Scientific Criteria for Environmental Quality, Subcomittees on Pesticides and Related Compounds and Biological Phenomena) ; sigma exotoxin which has a structure similar to beta-exotoxin, and is also active against Leptinotarsa decemlineata (Argauer et al . , 1991,- J. Entomol . Sci . 26:206-213); and anhydrothuringiensin (Prystas et al . , 1975, Coll . Czechosslovak Chem. Comm . 40:1775) . 2.2. ZWITTERMICIN A substance has been isolated from Bacillus cereus which inhibits the growth of the plant pathogen Phytophthora medicaginis and reduces the infection of alfalfa (see, for example, U.S. Patent Nos. 4,877,738 and 4,878,936). No other activity was disclosed. The following structure has been elucidated for zwittermicin A (He et al . , Tet. Lett. 35:2499- 2502 ) : 3. OBJECTS OF THE INVENTION The art has strived to achieve increased mortality of B . t . formulations. Means have included searching for new strains with increased mortality, attempting to engineer present strains, and attempting to design more effective formulations by combining 23.t. spores and crystals with new pesticidal carriers chemical pesticides, or enhancers (see, for example, U.S. Patent No. 5,250,515, a trypsin inhibitor). It is therefore an object of the present invention to potentiate the pesticidal activity of pesticides. It is also an object of the invention to isolate strains that produce large amounts of potentiator. 4. SUMMARY OF THE INVENTION The invention relates to a mutant Bacillus strain which produces a factor which potentiates the pesticidal activity of a Bacillus related pesticide, wherein the amount of the factor produced by the mutant is greater than the amount of the factor produced by a corresponding parental strain. In a specific embodiment, the Bacillus strain is selected from the group consisting of Bacillus subtilus, Bacillus licheniformis, and Bacillus thuringiensis . The factor produced by said mutant is a potentiator. As defined herein, a "potentiator" is a substance which has no significant pesticidal activity, e.g., having an LC 50 (LC 50 is the concentration of the substance required to kill 50% of the pests) of more than about 3000 μg/g as assayed by bioassay (see Section 6) but acts to increase the pesticidal activity of a Bacillus related pesticide at least about 50% and does not cause larval stunting. As noted in Section 2, other substances capable of enhancing pesticidal activity known in the art such as delta-endotoxins, trypsin inhibitors and exotoxins have pesticidal activity. In a specific embodiment, the factor is water soluble. As defined herein, a substance or compound is "water soluble" if at least about 1 mg of a substance can be dissolved in 1 ml of water. The factor may also potentiate the pesticidal activity of a chemical pesticide and/or a virus with pesticidal properties. As defined herein, "a Bacillus related pesticide" is a Bacillus (e.g., Bacillus thuringiensis or Bacillus subtilis) strain, spore, or substance, e.g., protein or fragment thereof having activity against or which kill pests or a microorganism capable of expressing a Bacillus gene encoding a Bacillus protein or fragment thereof having activity against or which kill pests (e.g., Bacillus thuringiensis delta-endotoxin) and an acceptable carrier (see Section 5.2., infra, for examples of such carriers) . The pest may be, for example, an insect, a nematode, a mite, or a snail. A microorganism capable of expressing a Bacillus gene encoding a Bacillus protein or fragment thereof having activity against or which kill pests inhabits the phylloplane (the surface of the plant leaves) , and/or the rhizosphere (the soil surrounding plant roots) , and/or aquatic environments, and is capable of successfully competing in the particular environment (crop and other insect habitats) with the wild-type microorganisms and provide for the stable maintenance and expression of a Bacillus gene encoding a Bacillus protein or fragment thereof having activity against or which kill pests. Examples of such microorganisms include but are not limited to bacteria, e.g., genera Bacillus, Pseudomonaε , Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, Alcaligenes, and Clostridium; algae, e.g., families Cyanophyceae, Prochlorophyceae, Rhodophyceae, Dinophyceae, Chrysophyceae, Prymnesiophyceae, Xanthophyceae, Raphidophyceae, Bacillariophyceae , Eustigmatophyceae, Cryptophyceae, Euglenophyceae, Prasinophyceae, and Chlorophyceae; and fungi, particularly yeast, e.g., genera Saccharomyces, Cryptococcus , Kluyveromyces , Sporobolomyces , Rhodotorula, and Aureobasidiu . As defined herein, "pesticidal activity" measures the amount of activity against a pest through killing or stunting of the growth of the pest or protecting the plant from pest infestation. The invention also relates to a method for obtaining the mutant of the present invention comprising: (a) treating a Bacillus strain with a mutagen; (b) growing the mutated Bacillus strain of step (a) under suitable conditions for selecting the mutant; and (c) selecting the mutant of step (b) . Substantially pure factor may be obtained from the mutant by: (a) culturing a mutant of a Bacillus strain under suitable conditions; (b) recovering a supernatant of the culture of the mutant of step (a) and (c) isolating the factor from the supernatant of step (b) to obtain the substantially pure factor. The factor obtained from said mutant may be formulated into a composition comprising the factor and a pesticidal carrier as well as the factor and a Bacillus related pesticide, chemical pesticide and/or a virus with pesticidal properties. These compositions may be used for controlling a pest, decreasing the resistance of a pest to a Bacillus related pesticide comprising exposing the pest to a composition comprising the factor and a pesticidally acceptable carrier, or potentiating the pesticidal activity of a Bacillus related pesticide. 5. BRIEF DESCRIPTION OF THE FIGURES Figure 1 schematically shows the general procedure used for purifying la. Figure 2 shows the 13 C NMR spectrum of la. Figure 3 shows the proton NMR spectrum of la. Figure 4 shows the results of nOe experiments on the acetylated derivative of la. 6. DETAILED DESCRIPTION OF THE INVENTION The parental Bacillus strain may be, e.g., Bacillus subtilis, Bacillus licheniformis, or Bacillus thuringiensis . The parental Bacillus thuringiensis may be a wild-type strain which includes but is not limited to Bacillus thuringiensis subsp. kurstaki , Bacillus thuringiensis subsp. aizawai , Bacillus thuringiensis subsp. galleriae, Bacillus thuringiensis subsp. entomocidus, Bacillus thuringiensis subsp. tenebrionis, Bacillus thuringiensis subsp: thuringiensis. Bacillus thuringiensis subsp. alesti , Bacillus thuringiensis subsp. canadiensis. Bacillus thuringiensis subsp. darmstadiensis, Bacillus thuringiensis subsp. dendrolimus, Bacillus thuringiensis subsp. finitimus, Bacillus thuringiensis subsp. kenyae, Bacillus thuringiensis subsp. morrisoni , Bacillus thuringiensis subsp. subtoxicus, Bacillus thuringiensis subsp. toumanoffi , Bacillus thuringiensis subsp. toumanoffi , Bacillus thuringiensis subsp. pondicheriensis, Bacillus thuringiensis subsp. shandogiensis , Bacillus thuringiensis subsp. sot to, Bacillus thuringiensis subsp. nigeriae, Bacillus thuringiensis subsp. yunnanensis , Bacillus thuringiensis subsp. dakota, Bacillus thuringiensis subsp. nidiana, Bacillus thuringiensis subsp. tohokuensis , Bacillus thuringiensis subsp. kumamotoensiε , Bacillus thuringiensis subsp. tochigiensis, Bacillus thuringiensis subsp. thompsoni , Bacillus thuringiensis subsp. wuhanensis, Bacillus thuringiensis subsp. kyushuensis, Bacillus thuringiensis subsp. ostriniae, Bacillus thuringiensis subsp. tolworthi , Bacillus thuringiensis subsp. Pakistani , Bacillus thuringiensis subsp. japonensis , Bacillus thuringiensis subsp. colmeri , Bacillus thuringiensis subsp. pondicheriensis , Bacillus thuringiensis subsp. Shandong iens is, Bacillus thuringiensis subsp. neoleonensis, Bacillus thuringiensis subsp. coreanensis, Bacillus thuringiensis subsp. silo, Bacillus thuringiensis subsp. mexcanensis, and Bacillus thuringiensis subsp. israelensis . In a specific embodiment, the parental Bacillus thuringiensis strain is Bacillus thuringiensis subsp. kurstaki . In a most specific embodiment, the parental strain is Bacillus thuringiensis subsp. kurstaki strain EMCC0086 (deposited with the NRRL as NRRL B-21147). The mutant in yet another specific embodiment has the identifying characteristics of EMCC0129, deposited with the NRRL and having the accession number NRRL B- 21445, or has the identifiying characteristics of EMCC0130, deposited with the NRRL and having the accession number NRRL B- 21444. 6.1. METHODS OF OBTAINING THE MUTANT The parental strain may be treated with a mutagen to induce a mutational event. Specifically, in one method of mutating Bacillus thuringiensis strains and selecting such mutants that are capable of producing substantially larger amounts of factor than their parental strains, the parental strain is: i) treated with a mutagen, ii) the treated cells are cultured in a suitable culture medium (e.g., NSMP medium); and iii) cells are selected which produce a larger amount of factor. In step (i) , the mutagen for example may be a chemical mutagen N-methyl-N'-nitro-N-nitrosoguanidine, N,N'-dinitro-N'- nitrosoguanidine, or ethyl methanesulfonate, gamma irradiation, X-ray and/or UV-irradiation. The cells are selected by assaying for the production of the factor, for example, by capillary electrophoresis or immunoassay using an antibody to the factor. Another method of obtaining the high producing mutants of the invention may be contemplated such as growing the parent strain in a liquid medium and selecting spontaneous mutants after spreading the culture broth on an agar medium suitable for selection of mutants. Other methods of screening for the high producing mutants of the invention may be contemplated such as separating the mutants from other material on the basis of mass directly through centrifugation or other means of separating for mass. 6.2. OBTAINING THE FACTOR The Bacillus mutants of the present invention may be cultured using media and fermentation techniques known in the art (see, for example, Rogoff et al . , 1969, J. Invertebrate Path. 14:122-129; Dulmage et al . , 1971, J. Invertebrate Path. 18:353-358; Dulmage et al . , in Microbial Control of Pests and Plant Diseases, H.D. Burges, ed., Academic Press, N.Y., 1980). In a specific embodiment, the fermentation media may comprise hydrolyzed protein, hydrolyzed carbohydrate, salts, and trace metal. The fermentation media may also optionally comprise one or more amino acids. Upon completion of the fermentation cycle, the supernatant can be recovered by separating B.t. spores and crystals from the fermentation broth by means well known in the art, e.g., centrifugation and/or ultrafiltration. The factor is contained in the supernatant which may be recovered by means well known in the art, e.g., ultrafiltration, evaporation, and spray-drying. This procedure is more specifically described in the sections which follow. Purification of the factor can be carried out by various procedures known in the art, including but not limited to chromatography (e.g., ion exchange, affinity, and size exclusion column chromatography) , electrophoretic procedures, differential solubility, extraction, or any other standard technique known in the art. The potentiating activity of the factor of the pesticidal activity of Bacillus related pesticide, virus having pesticidal activity, or chemical pesticide against various pests may be assayed using procedures known in the art, such as an artificial insect diet incorporated, artificial diet overlay, leaf painting, leaf dip, and foliar spray. Specific examples of such assays are given in Section 7, infra . The amount of factor produced may be quantitated, for example, by capillary electrophoresis. The factor may have a molecular weight of from about 350 to about 1200 or in a specific embodiment from about 350 to about 700. The factor potentiates the pesticidal activity of a Bacillus related pesticide at least about 1.5 fold to optionally about 1000 fold, preferably from about 100 fold to about 400 fold. In a specific embodiment, the factor potentiates the pesticidal activity of a Bacillus thuringiensis delta-endotoxin including but not limited to a Cryl (including but not limited to CrylA, CrylB, and CrylC) , Cryll, Crylll, CryIV, CryV, or CryVI protein in full-length form or a proteolytically processed, truncated form, from about 1.5 fold to about 1000 fold. In a most specific embodiment, the factor potentiates a B. t . delta-endotoxin from about 100 fold to about 400 fold. The factor may also potentiate the pesticidal activity of a chemical pesticide and/or a virus with pesticidal properties. The factor may also be water soluble, stable in water up to about 100°C for at least about 5 minutes, stable when subjected to direct sunlight for at least about 10 hours, and/or stable at a pH of about 2 for about 10 days. The factor may have 13 carbons. Additionally, the factor may have *H NMR shifts at about δl.5, 3.22, 3.29, 3.35, 3.43, 3.58, 3.73, 3.98, 4.07, 4.15, 4.25, 4.35 and «c shifts at about 31.6, 37.2, 51.1, 53.3, 54.0, 54.4, 61.5, 61.6, 64.1, 65.6, 158.3, 170.7, and 171.3. In a most specific embodiment said factor has the structure la or salt thereof . The salt would be capable of potentiating a Bacillus related pesticide. 6 .3 . COMPOSITIONS COMPRISING THE FACTOR The factor obtained from the mutants of the present invention can be formulated alone; with a Bacillus related pesticide, which as defined, supra, is a Bacillus strain, spore, protein or fragment, or other substance, thereof, with activity against or which kills pests or protects plants against a pest; with a chemical pesticide and/or an entomopathogenic virus and an acceptable carrier into a pesticidal composition(s) , that is, for example, a suspension, a solution, an emulsion, a dusting powder, a dispersible granule, a wettable powder, an emulsifiable concentrate, an aerosol or impregnated granule. Examples of such Bacillus strains include, but are not limited to, Bacillus thuringiensis subsp. kurstaki (marketed as DIPEL™ from Abbott Laboratories, Inc., JAVELIN™ from Sandoz, BIOBIT™ from Novo Nordisk A/S, FORAY™ from Novo Nordisk A/S, BIOCOT™ from Novo Nordisk A/S, MVP™ from Mycogen, BACTOSPEINE™ from Novo Nordisk A/S, and THURICIDE™ from Sandoz); Bacillus thuringiensis subsp. aizawai (marketed as FLORBAC™ from Novo Nordisk A/S, and XENTARI™ from Abbott Laboratories, Inc.); Bacillus thuringiensis subsp. tenebrionis (marketed as NOVODOR™ from Novo Nordisk A/S, TRIDENT™ from Sandoz, M-TRAK™ and M-ONE™ from Mycogen, and DITERRA™ from Abbott Laboratories Inc.); Bacillus thuringiensis subsp. israelensis (marketed as either BACTIMOS™ or SKEETAL™ from Novo Nordisk A/S, TEKNAR™ from Sandoz, and VECTOBAC™ from Abbott Laboratories, Inc.); Bacillus thuringiensis kurstaki /tenebrionis (marketed as FOIL™ from Ecogen) ,- Bacillus thuringiensis kurstaki/ aizawai (marketed as CONDOR™ from Ecogen and AGREE™ from Ciba-Geigy) ; and Bacillus thuringiensis kurstaki/kurstaki (marketed as CUTLASS™ from Ecogen) . The Bacillus related protein may be selected from the group including, but not limited to, Cryl, Cryll, Crylll, CryIV, CryV, and CryVI. The chemical pesticide may be, for example, an insect growth regulator such as diflubenzuron, a carbamate such as thiodicarb and methomyl, an organophosphate such as chlorpyrifos, a pyrethroid such as cypermethrin and esfenvalerate, inorganic fluorine such as cryolite, and a pyrrole. The entomopathogenic virus may be a baculovirus, e.g., Autographa californica nuclear polyhedrosis virus (NPV) , Syngrapha falcifera NPV, Cydia pomonella GV (granulosis virus) , Heliothis zea NPV, Lymantria dispar NPV, Orgyia pseudotsugata NPV, Spodoptera exigua NPV, Neodiprion lecontei NPV, Neodiprion sertifer NPV, Harrisina brillians NPV, and Endopiza vi teana Clemens NPV. In compositions comprising the substance and a Bacillus related pesticide, the substance may be present in the amount of at least about 0.1 g/BIU or 0.05 g factor per g Bacillus delta-endotoxin and spore, optionally to about 300 g/BIU or 150 g substance per g Bacillus delta-endotoxin and spore, preferably 2 g/BIU or 1 g substance per g Bacillus delta- endotoxin and spore. As defined herein "BIU" is billion international units as determined by bioassay. The bioassay compares the sample to a standard Bacillus reference material using Trichoplusia ni or other pest as the standard test insect. The potency is determined by dividing the reference standard LC 5 0 then multiplying by the reference standard potency. In another embodiment, the composition may comprise the factor in substantially pure form or a supernatant from Bacillus in dry, concentrated, or liquid form and a pesticidally acceptable carrier, examples of which are disclosed, infra . This composition may be applied separately to a plant, e.g., transgenic plants. Specifically, the composition may be applied to a plant previously containing and expressing a Bacillus thuringiensis gene. In another embodiment, the composition may be applied to a plant previously exposed to a Bacillus thuringiensis composition. In another embodiment, the composition may be applied to other environments of a dipteran pest(s), e.g., water or soil. The substance is present in the composition at a concentration of about 0.001% to about 60% (w/w) . The composition comprising the substance and a pesticidally acceptable carrier in addition to controlling a pest may also be used to decrease the resistance of a pest to a pesticide. Alternatively, the composition may be used to potentiate a Bacillus related pesticide. The composition in one embodiment may be applied at the same time as the pesticide in an amount of at least about 2 g substance/BIU up to optionally about 300 g substance/BIU. in another embodiment, the composition may be applied up to about 24 hours after the pesticide as an adjuvant to extend the efficacy of residual pesticide. Such compositions disclosed above may be obtained by the addition of a surface active agent, an inert carrier, a preservative, a humectant, a feeding stimulant, an attractant, an encapsulating agent, a binder, an emulsifier, a dye, a U.V. protectant, a buffer, a flow agent, or other component to facilitate product handling and application for particular target pests. Suitable surface-active agents include anionic compounds such as a carboxylate, for example, a metal carboxylate of a long chain fatty acid; a N-acylsarcosinate; mono or di-esters of phosphoric acid with fatty alcohol ethoxylates or salts of such esters; fatty alcohol sulphates such as sodium dodecyl sulphate, sodium octadecyl sulphate or sodium cetyl sulphate; ethoxylated fatty alcohol sulphates; ethoxylated alkylphenol sulphates; lignin sulphonates; petroleum sulphonates; alkyl aryl sulphonates such as alkyl- benzene sulphonates or lower alkylnaphthalene sulphonates, e.g., butyl-naphthalene sulphonate; salts or sulphonated naphthalene- formaldehyde condensates; salts of sulphonated phenol- formaldehyde condensates; or more complex sulphonates such as the amide sulphonates, e.g., the sulphonated condensation product of oleic acid and N-methyl taurine or the dialkyl sulphosuccinates, e.g., the sodium sulphonate or dioctyl succinate. Non-ionic agents include condensation products of fatty acid esters, fatty alcohols, fatty acid amides or fatty- alkyl- or alkenyl-substituted phenols with ethylene oxide, fatty esters of polyhydric alcohol ethers, e.g., sorbitan fatty acid esters, condensation products of such esters with ethylene oxide, e.g., polyoxyethylene sorbitar fatty acid esters, block copolymers of ethylene oxide and propylene oxide, acetylenic glycols such as 2,4,7,9-tetraethyl-5-decyn-4,7-diol, or ethoxylated acetylenic glycols. Examples of a cationic surface- active agent include, for instance, an aliphatic mono-, di-, or polyamine as an acetate, naphthenate or oleate; an oxygen- containing amine such as an amine oxide of polyoxyethylene alkylamine; an amide-linked amine prepared by the condensation of a carboxylic acid with a di- or polyamine; or a quaternary ammonium salt. Examples of inert materials include inorganic minerals such as kaolin, mica, gypsum, fertilizer, phyllosilicates, carbonates, sulfates, or phosphates; organic materials such as sugar, starches, or cyclodextrins; or botanical materials such as wood products, cork, powdered corncobs, rice hulls, peanut hulls, and walnut shells. The compositions of the present invention can be in a suitable form for direct application or as a concentrate or primary composition which requires dilution with a suitable quantity of water or other diluent before application. The pesticidal concentration will vary depending upon the nature of the particular formulation, specifically, whether it is a concentrate or to be used directly. The composition contains 1 to 98% of a solid or liquid inert carrier, and 0 to 50%, preferably 0.1 to 50% of a surfactant. These compositions will be administered at the labeled rate for the commercial product, preferably about 0.01 pound to 5.0 pounds per acre when in dry form and at about 0.01 pint to 25 pints per acre when in liquid form. In a further embodiment, the Bacillus thuringiensis crystal delta-endotoxin and/or factor can be treated prior to formulation to prolong the pesticidal activity when applied to the environment of a target pest as long as the pretreatment is not deleterious to the crystal delta-endotoxin or substance. Such treatment can be by chemical and/or physical means as long as the treatment does not deleteriously affect the properties of the composition(s) . Examples of chemical reagents include, but are not limited to, halogenating agents; aldehydes such as formaldehyde and glutaraldehyde; anti-infectives, such as zephiran chloride; alcohols, such as isopropranol and ethanol; and histological fixatives, such as Bouin's fixative and Helly's fixative (see, for example, Humason, Animal Tissue Techniques, W.H. Freeman and Co., 1967). The compositions of the invention can be applied directly to the plant by, for example, spraying or dusting at the time when the pest has begun to appear on the plant or before the appearance of pests as a protective measure. Plants to be protected within the scope of the present invention include, but are not limited to, cereals (wheat, barley, rye, oats, rice, sorghum and related crops), beets (sugar beet and fodder beet) , drupes, pomes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, and blackberries) , leguminous plants (alfalfa, beans, lentils, peas, soybeans), oil plants (rape, mustard, poppy, olives, sunflowers, coconuts, castor oil plants, cocoa beans, groundnuts), cucumber plants (cucumber, marrows, melons), fibre plants (cotton, flax, hemp, jute) , citrus fruit (oranges, lemons, grapefruit, mandarins) , vegetables (spinach, lettuce, asparagus, cabbages and other brassicae, carrots, onions, tomatoes, potatoes), lauraceae (avocados, cinnamon, camphor), deciduous trees and conifers (linden-trees, yew-trees, oak- trees, alders, poplars, birch-trees, firs, larches, pines), or plants such as maize, turf plants, tobacco, nuts, coffee, sugar cane, tea, vines, hops, bananas and natural rubber plants, as well as ornamentals. The composition can be applied by foliar, furrow, broadcast granule, "lay-by", or soil drench application. It is generally important to obtain good control of pests in the early stages of plant growth as this is the time when the plant can be most severely damaged. The spray or dust can conveniently contain another pesticide if this is thought necessary. In a preferred embodiment, the composition of the invention is applied directly to the plant. The compositions of the present invention can also be applied directly to ponds, lakes, streams, rivers, still water, and other areas subject to infestation by dipteran pests, especially pests of concern to public health. The composition can be applied by spraying, dusting, springling, or the like. The compositions of the present invention may be effective against insect pests of the order Lepidoptera, e.g., Achroia grisella, Acleris gloverana, Acleris variana, Adoxophyeε orana, Agrotiε ipεilon , Alabama argillacea, Alεophila pometaria, Amyeloiε transitella, Anagasta kuehniella, Anarsia lineatella, Anisota εenatoria, Antheraea pernyi , Anticarεia gemmataliε, Archips sp . , Argyrotaenia sp . , Athetiε mindara, Bombyx mori , Bucculatrix thurberiella, Cadra cautella, Choriεtoneura εp. , Cochyliε hoεpeε, Coliaε eurytheme, Corcyra cephalonica, Cydia la iferreanus, Cydia pomonella, Datana integerrima, Dendrolimuε εibericuε, Deεmia funeraliε, Diaphania hyalinata, Diaphania nitidalis, Diatraea grandioεella, Diatraea εaccharaliε, Ennomoε subεignaria, Eoreuma loftini , Epheεtia elutella, Eranniε tiliaria, Eεtigmene acrea, Eulia εalubricola, Eupoecilia ambiguella, Euproctiε chryεorrhoea, Euxoa essoria, Galleria mellonella, Grapholita moleεta, Harriεina americana, Helicoverpa εubflexa, Helicoverpa zea, Heliothiε virescenε, Hemileuca oliviae, Homoeoεoma electellum, Hyphantria cunea, Keiferia lycoperεicella, Lambdina fiεcellaria fiεcellaria, Lambdina fiεcellaria lugubrosa, Leucoma saliciε, Lobeεia botrana, Loxoεtege εticticaliε, Lymantria diεpar, Macalla thyrsiεaliε, Malacoεoma εp. , Mamestra brasεicae, Ma eεtra configurata, Manduca guinguemaculata, Manduca εexta, Maruca teεtulaliε, Melanchra picta, Operophtera brumata, Orgyia εp. , Oεtrinia nuJbilalis, Paleacrita vernata , Papilio creεphonteε, Pectinophora goεεypiella, Phryganidia californica, Phyllonorycter blancardella, Pieriε napi , Pieriε rapae, Plathypena εcabra, Platynota flouendana, Platynota εul tana, Platyptilia carduidactyla, Plodia interpunctella, Plutella xyloεtella, Pontia protodice, Pεeudaletia unipuncta, Pεeudopluεia includenε, Sabulodeε aegrotata, Schizura concinna, Si totroga cerealelia, Spilonota ocellana, Spodoptera εp . , Thaurnεtopoea pi tyocampa, Tineola biεselliella, Trichopluεia ni , Udea rubigaliε, Xylomygeε curialiε, Yponomeuta padella; order Diptera, e.g., Aedeε εp . , Andes vittatuε, Anaεtrepha ludenε, Anastrepha suεpenεa, Anopheleε barber i, Anopheleε quadrimaculatuε , Armigereε εubalbatuε , Calliphora εtygian, Calliphora vicina, Ceratitiε capi tata, Chironomuε tentanε, Chryεomya rufifacieε, Cochliomyia macellaria, Culex εp. , Culiεeta inornata, Dacuε oleae, Delia antiqua, Delia platura, Delia radicum, Droεophila melanogaε ter, Eupeodeε corollae, Glossina auεteni , Gloεεina brevipalpiε, Gloεεina fuεcipeε, Gloεεina morεitans centraliε, Gloεεina morεi tanε morεitanε, Gloεεina moriεtans εubmorεi tanε, Glossina pallidipes, Gloεεina palpaliε gambiensis, Gloεεina palpaliε palpaliε, Gloεεina tachinoideε, Haemagoguε equinuε, Haematobia irri tanε, Hypoderma bovis, Hypoderma lineatum, Leucopiε ninae, Lucilia cuprina, Lucilia εericata, Lutzomyia longlpaipiε, Lutzomyia εhannoni , Lycoriella mali , Mayetiola deεtructor, Muεca autumnaliε, Muεca domeεtica, Neobellieria εp. , Nephrotoma εuturaliε, Ophyra aenescenε, Phaenicia εericata, Phlebotomus sp. , Phormia regina, Sabethes cyaneuε, Sarcophaga bullata, Scatophaga εtercoraria, Stomoxys calci tranε, Toxorhynchi tes amboinensiε, Tripteroides bambusa . However, the compositions of the invention may also be effective against insect pests of the order Coleoptera, e.g., Leptinotarεa εp. , Acanthoεcelideε obtectuε, Calloεobruchus chinensiε, Epilachna variveεtis, Pyrrhalta luteola, Cylaε formicariuε elegantuluε, Liεtronotuε oregonenεiε, Sitophiluε sp. , Cyclocephala borealiε, Cyclocephala immaculata, Macrodactyluε εubεpinosuε, Popillia japonica, Rhizotrogus majalis, Alphitobiuε diaperinuε, Palorus ratzeburgi , Tenebrio molitor, Tenebrio obscuruε, Tribolium castaneum, Tribolium confuεum, Triboliuε deεtructor; Acari, e.g., Oligonychus pratenεiε, Panonychuε ulmi , Tetranychuε urticae; Hymenoptera, e.g., Iridomyrmex humiliε, Solenopεiε invicta ; ΛMΛ WO 96/38539 Isoptera, e.g. , Reticulitermeε hesperuε , Reticulitermes flavipeε, Coptotermeε formosanuε, Zootermopεiε angusticolliε , Neotermeε connexuε, Inciεitermeε minor, Inciεitermeε immigranε; Siphonaptera, e.g., Ceratophyllus gallinae, Ceratophylluε niger, Noεopεyllus faεciatuε, Leptopεylla segnis, Ctenocephalides canis, Ctenocephalides felis, Echicnophaga gallinacea, Pulex irri tans, Xenopsylla cheopiε, Xenopεylla vexabilis, Tunga penetranε; and Tylenchida, e.g., Melodidogyne incogni ta, Pratylenchuε penetranε . The following examples are presented by way of illustration, not by way of limitation. 7. EXAMPLE: CHARACTERIZATION OF la As detailed herein, la is recovered and purified. The characterization of la is detailed infra . 7.1. RECOVERY AND PURIFICATION OF la B. thuringiensis subsp. kurstaki strain EMCC0086 (deposited with the NRRL as B-21147) is fermented for 72 hours at 30°C in a medium comprised of a carbon source such as starch, hydrolyzed starch, or glucose and a nitrogen source such as protein, hydrolyzed protein, or corn steep liquor. The production of la is detected at 13 hours into the fermentation. Peak activity is found to be at approximately 30 hours. Supernatant from a B. thuringienεiε subsp. kurεtaki fermentation is recovered by centrifugation and then is clarified by ultrafiltration through a 30 kDa MW-CO membrane using a Rhone Poulenc UF system. The 30 kDa filtration removed any remaining cell debris, crystal delta-endotoxin, spores, and soluble protein greater than 30 kDa molecular mass. The permeate is concentrated 10 fold by evaporation. The permeate is centrifuged and then 0.2μ filtered to further remove insolubles from the broth, leaving a clear broth containing la. The purification of la to homogeneity is achieved using a multi-step purification procedure shown schematically in Figure 1. In conjunction with the recovery protocol outlined above, the purification proceeded with a 5 kDa ultrafiltration step. The permeate from the 5 kDa ultrafiltration is adsorbed to a Sulfopropyl (SP) cation exchange resin and eluted with an ammonium acetate solution. The compound is then concentrated approximately 30X by lyophilization, and the salt and other contaminants are removed with a BioRad P2 size exclusion column. The pool from the P2 column is run over a high resolution SP HPLC cation exchange column which yielded a homogeneous compound. The contaminating salt is removed by repeated lyophilization. Activity is monitored by a Spodoptera -exigua micro- bioassay, and purity is determined by capillary electrophoresis. Sample consisting of 50 μl of la and 50 μl of CrylA(c) protein (15 μg/ml) purified from BIOBIT™ FC (100 μl) , is applied to individual wells of a jelly tray containing 500 μl of solidified artificial insect diet. The trays containing the various samples are air dried. Two to four 2nd or early 3rd instar Spodoptera exigua are added to the wells containing the dried sample. The wells are sealed with mylar poked with holes and are incubated for 2-3 days at 30°C. Degree of stunting and percent mortality are then recorded. Typically, 5 replicate wells are run for each sample. 7.2. STRUCTURE ELUCIDATION The active compound is found to be water soluble but is not soluble in organic solvents. It is positively charged and reacted with ninhydrin as evidenced by silica thin layer chromatography. 13 C and proton NMR of the compound are shown in Figures 2 and 3, respectively. 13 C NMR experiments revealed the presence of 13 carbons (referenced to 3-[trimethylsilyl propionic acid) . A DEPT experiment determined that there are three quaternary carbons (C) , seven methines (CH) , three methylenes (CH 2 ) and no methyl groups (CH 3 ) . Using proton coupling experiments such as 1-D decoupling and COSY, one large spin system containing eight carbons is identified. In addition, a smaller spin system consisting of two carbons is present. A carbon proton correlation experiment (HMBC) enabled assignment of each proton resonance in the molecule to its attached carbon. Treatment of the active compound (13 mg) with acetic anhydride in pyridine resulted in the formation of an acetylated derivative which is much less polar. This derivative is purified by HPLC to give 3 mg of pure acetylated derivative. Mass spectroscopy analysis revealed that the derivative has 7 acetates and a molecular weight of 690, which gives a molecular weight of 396 for the active compound and indicates that an even number of nitrogens are present. Also, fragments containing 6 acetates and 5 acetates are detected. High resolution data for 5 and 6 acetate daughter ions are 645.2594 (6 acetates) and 607.2519 (5 acetates) which indicate the following molecular formula for la, C 13 H 2B N60 8 . Treatment of the active compound (13 mg) with 6 N HCl gave a derivative which is ninhydrin positive. These results indicate the presence of amide bonds. The derivative had the same R f value as determined by thin layer chromatography as 2,3- diaminopropionic acid. These results along with NMR data, suggest the presence of 2,3 diaminopropionic acid. Another technique used to analyzed la is nOe (Nuclear Overhauser Effect) which can detect proximity of protons to one another through space. nOe is carried out on an acetylated derivative of la. In a two dimensional nOe experiment (NOESY) , nOes are observed between an N-H proton at 8.06 ppm and the 5.17 proton (Figure 4) . The following structure has been elucidated for la It can be classified as a ureido amide. Constituents include 2 amides, a urea, two aminos, and five hydroxyls. It contains seven chiral centers. 7.3. PROPERTIES OF la The isolated la is found to potentiate the activity of Bacilluε thuringienεiε subsp. kurεtaki and Bacilluε thuringienεiε subsp. aizawai crystal delta-endotoxin pesticidal proteins toward Spodoptera exigua regardless of the form of the pesticidal proteins. The pesticidal activity of formulated B . t . k. , isolated crystals, full-length (130 kDa molecular mass) or truncated CrylA proteins (-65 kDa molecular mass) are all potentiated. The activity of CryII and CrylC inclusions are also potentiated. It is also found to potentiate the activity of the individual truncated CryΙA(a) , (b) , and (c) proteins. Incubation time of la with the Cry protein is not found to be critical for bioactivity. However, la is inactive alone. The level of potentiation is found to be 100-200 fold for the truncated CrylA proteins, Cryll and CrylC inclusions and approximately 320 fold with full-length CryΙA(c) (see Tables I and II respectively) . Specifically, for full-length protein, 0.75 μg/ml CrylA(c) produced the same insect mortality/stunt score when la is included as 240 μg/ml of CrylA(c) alone. In the case of the truncated CrylA(c) , an OD 280 of 0.0006 gave the same stunt score in combination with la as the same sample of CrylA(c) tested alone with an OD 2 8o of 0.075. Cryll inclusions, at a concentration of 0.6 μg/ml gave the same stunt score and similar mortality in combination with la as Cryll protein alone at 75 μg/ml, a 125 fold potentiation. CrylC inclusions, at 0.3 μg/ml with the addition of la gave similar mortality and stunt score as 75 μg/ml of the CrylC protein alone, which reflects a 250 fold level of potentiation. The concentration of CrylA protein that produced stunting yielded mortality on addition of la. la is found to be stable upon boiling for 5 minutes, but loses all activity upon autoclaving (>190C) . Further, it is stable when subjected to direct sunlight for at least 10 hours, la is stable at pH 2 for 3 days, but unstable at pH 12. It is found to lose all activity when exposed to periodic acid or concentrated HCl. TABLE I POTENTIATION EFFECTS OF la WITH PURIFIED TRUNCATED Bt PROTEIN Bt Proteir L Spodovtera Exiσua Type. OD280 Ic Mortality* Stunt Scoret Cryla(a) 0.055 — 0/5 2.2 0.040 — 0/5 2.2 0.020 — 0/5 2.0 0.020 + 2/5 0.0 0.010 + 0/5 0.2 0.005 + 0/5 0.0 0.0025 + 0/5 0.4 0.0012 + 0/5 1.8 0.0006 + 0/5 1.6 CrylA(c) 0.075 — 0/5 3. 0.040 — 0/5 2. 0.020 — 0/5 2. 0.020 + 1/5 0, 0.010 + 0/5 0, 0.005 + 1/5 0.0 0.0025 + 2/5 2.0 0.0012 + 0/5 1.0 0.0006 + 1/5 1.0 None NA + 0/5 4.0 None NA — 0/5 4.0 * Mortality = # insects dead/# total insects after 2 days t Stunt score is defined by the average size of the live insect larvae at the end of the bioassay: 4.0 = untreated control, 3.0 = 75% size of untreated control, 2.0 = 50% size of untreated control, 1.0 = 25% size of untreated control, 0.0 = no growth or size unchanged from start of experimen . TABLE II POTENTIATION EFFECTS OF la WITH Bt PROTEIN Bt Protein Spodoptera Exiσua Type μσ/ml la Mortality* Stunt Scoret CryΙA(c) 240 - 1/5 0.5 120 - 0/5 2.2 60 - 0/5 2.2 30 - 0/5 4.0 60 + 5/5 30 + 5/5 15 + 4/5 0.0 3 + 4/5 1.0 0.8 + 2/5 1.6 Cryll 300 - 1/5 0.8 150 - 2/5 0.7 75 - 1/5 0.2 38 - 0/5 0.8 19 - 0/5 1.6 9 - 0/5 1.8 5 - 1/5 4.0 38 + 3/5 1.0 19 + 2/5 0.5 9 + 3/5 0.0 5 + 1/5 0.5 2.4 + 1/5 0.0 1.2 + 3/5 0.5 0.6 + 2/5 0.3 Cryll 300 - 2/5 - 0.3 150 - 2/5 0.0 75 - 1/5 0.8 38 - 0/5 3.2 38 + 5/5 19 + 5/5 9 + 5/5 5 + 4/5 0.0 2.4 + 1/5 0.0 1.2 + 5/5 0.6 + 3/5 1.5 0.3 + 2/5 1.3 None NA - 0/5 4.0 None NA + 0/5 4.0 * Mortality = # insects dead/# total insects after 2 days t Stunt score is defined by the average size of the live insect larvae at the end of the bioassay: 4.0 = untreated control, 3.0 = 75% size of untreated control, 2.0 = 50% size of untreated control, 1.0 = 25% size of untreated control, 0.0 = no growth or size unchanged from start of experimen . 7.4. EVALUATION OF OTHER SUBSPECIES OF Bacilluε thurinσienεis AND OTHER SPECIES OF Bacilli Several Bacilluε species are evaluated for production of la. The strains are fermented for 72 hours at 30°C in a medium comprised of a carbon source such as starch, hydrolyzed starch, or glucose and a nitrogen source such protein, hydrolyzed protein, or corn steep liquor. The supernatants are tested for la production using the Spodoptera exigua micro- bioassay described εupra . B . thuringiensis subsp. aizawai strain EMCC0087 (deposited with the NRRL as NRRL B-21148) and 23. thuringienεiε subsp. galleriae (deposited with the NRRL) are found to produce la in about the same concentration as B . thuringiensis subsp. kurstaki . la is also produced in B. εubtiliε, B. cereuε, B . t . subsp. aleεti , B.t. subsp. canadiensis, B. t . subsp. darmstadienεiε, B. t . subsp. dendroli uε, B. t . subsp. entomociduε, B. t . subsp. finitimuε, B. t . subsp. iεraelenεiε, B . t . subsp. kenyae, B . t . subsp. morriεoni , B. t . subsp. εubtoxicuε, B . t . subsp. tenebrioniε, B. t . subsp. thuringienεiε, and B.t. subsp. toumanoffi, B. cereuε, B. εubtiliε, and B . thuringiensis subsp. kurstaki cry- spo- mutant as determined by capillary electrophoresis. Specifically, a Beckman P/ACE Capillary Electrophoresis System equipped with a 50 μ x 57 cm uncoated capillary, 0.2 M phosphate pH 6.8 buffer, voltage at 15KV, and detection at 200 nm is used for quantifying the level of la. Sample volumes are 20 nl with a run time of 25 minutes. A standard curve is generated using purified la as the standard at levels of 1.25 mg/ml, 0.625 mg/ml, 0.3125 mg/ml, 0.156 mg/ml, and 0.078 mg/ml. A linear calibration curve is generated. The resultant y = mx + b equation is used to generate the concentration of la in each sample. Before each run, the capillary is flushed with running buffer (0.2 M phosphate, pH 6.8) for three minutes. After each 25 minute run, the capillary is flushed with 1 N NaOH for 1 minute, filtered HPLC water for 1 minute, 0.5 M phosphoric acid for 3 minutes, and filter HPLC water for 1 minute. The area under each peak is integrated and the peak area is determined and a final concentration is calculated from the standard curve. 7.5. EVALUATION OF B.t. PRODUCTS The amount of la present in various commercially available B . t . oroducts is determined by capillary electrophoresis described in Section 6.4, εupra . BACTOΞPEINE™, JAVELIN™, NOVODOR™, SPHERIMOS™, BACTIMOS™, FORAY™, FLORBAC™ and BIOBIT™ are obtained from Novo Nordisk A/S . XENTARI™ and DIPEL™ are obtained from Abbott Laboratories. AGREE™ is obtained from Ciba-Geigy; MVP™ is obtained from Mycogen and CUTLASS™ is obtained from Ecogen. The results are shown in Table III, infra and indicate that la is present in varying quantities ranging from less than 0.001 g Ia/BIU to 0.071 g Ia/BIU. TABLE III la IN Bacilluε thuringienεiε PRODUCTS 7.6. DIET INCORPORATION BIOASSAYS B . t . k. activity is determined by an artificial diet incorporation bioassay using third instar Spodoptera exigua larvae, second instar Helicoverpa zea larvae, third instar Spodoptera frugiperda larvae, second instar Heliothiε vireεcenε larvae, third instar Trichopluεia ni larvae, third instar Pεeudopluεia includenε larvae, third instar Plutella xyloεtella larvae, third instar Spodoptera li ttoraliε, and third instar Mameεtra braεεicae larvae. To determine the level of potentiation by adding la to B.t. products, and establish the range of insects that are affected, diet incorporation bioassays are performed. In the experiments with high concentrations of la against Spodoptera exigua (7.4-23.7 g Ia/BIU), purified la (70% active ingredient, 30% acetate counter ion) is used to potentiate BIOBIT™ FC (FC represents flowable concentrate) . The remaining data presented in Table IV shows the potentiation of BIOBIT™ HPWP (high potency wettable powder) with la (0.658% active ingredient). S. littoralis and M. brasεicae are tested using FLORBAC™ HPWP and la. The various B . t . products are weighed and la is added to give 0.1 to 237 g Ia/BIU. The volume is adjusted with 0.1% Tween™. The samples are sonicated for 1 minute and then diluted to final volume. Neat samples (without la) and reference substances are prepared as well. Reference substances include B . t . k. HD-l-S-1980 (obtained from the NRRL) which is assigned a potency of 16,000 international units (IU) per milligram and JAVELIN™ WG which has been assigned a potency of 53,000 Spodoptera Units/mg (SU) . Standard artificial diet composed of water, agar, sugar, casein, wheat germ, methyl paraben, sorbic acid, linseed oil, cellulose, salts, and vitamins are prepared in a 20 L heated kettle. This provides enough diet to test 10 to 12 samples with seven different concentrations of each test substance. The B.t. solutions are serially diluted to give 16 ml aliquots. Each aliquot is added to 184 g of molten diet. The mixture is subsequently homogenized and then poured into a plastic tray bearing 40 individual cells. Three control trays are prepared for each batch of diet. Once the diet has cooled and solidified, one insect of a known age (2-3 instar) is added to each cell, and the trays are covered with a perforated sheet of clear mylar. The trays are placed on racks and incubated for four days at 28'C and 65% relative humidity. After four days, insect mortality is rated. Each tray is given a sharp blow against a table top, and larvae that did not move are counted as dead. Percent mortality is calculated and the data is analyzed via parallel probit analysis. LC 50 S, LC 90 S, the slope of the regression lines, coefficient of variation, and potencies are estimated. Samples are run a minimum of 3 times or until three potencies are within 20% of a calculated mean for each sample. To calculate the increase in activity associated with each concentration of la, the LC 50 of the B.t./la sample is corrected to reflect the amount of B.t. in the sample. The LC50S of the paired neat samples are divided by the corrected LC50 values to give the fold reduction in LC 50 associated with la. The following procedure is used to assay for Lobeεia bothrana. Vine grapes attacked by Lobeεia bothrana axe collected in an unsprayed field and larva is removed. A dilution series of la (250 μg/ml, 500 μg/ml, and 1000 μg/ml) is made in water. One larva is put in the middle of the petri dish. If the larva is observed to drink, it is moved into a petri dish with freshly cut grape berries. The larvae are stored at 22'C for 3-4 days. As shown in Table IV, significant reductions in LC 50 S are observed for all species. TABLE IV Diet Incorporation Bioassays Increase in activity Insect σ l a p er B U Fold reduction in LC ^ n Spodoptera exigua 0 0..11 1 5 (BIOBIT™ HPWP) ( 0.22 l ' 7 2.0 4.3 4.0 7.5 Spodoptera exigua 7 7.44 13 (BIOBIT™ FC) 1 155 * 26 30 34 118 59 237 79 Spodoptera frugiperda 0 0.22 2 2 ( BIOBIT™ HPWP) 0 0^.88 3. ' 9 2.0 7.2 4.0 11.6 Trichoplusia ni 0 0..11 1 1 (BIOBIT™ HPWP) 0.2 1. 2.0 2. 4.0 3. Pseudoplusia includens 0.1 (BIOBIT™ HPWP) 0.2 0.8 2.0 2.4 4.0 3.4 Plutella xylostella 0 0..22 1 6 (BIOBIT™ HPWP) 0 0^. 8 8 1 ' 3 2.0 1.4 4.0 1.9 Helicoverpa zea 3.2 12.6 (BIOBIT™ HPWP) Heliothis virescens 3.2 4.2 (BIOBIT™ HPWP) Lobesia bothrana 2.0 3.0 (BIOBIT™ HPWP) Spodoptera littoralis 2.0 8.6 (FLORBAC™ HPWP) Mamestra brass icae 2.0 4.9 (FLORBAC™ HPWP) The potentiation of various products on Spodopt era exigua by la is determined using diet incorporation bioassays described εupra. Amounts of la added/BIU product are shown in Table V, infra. Ia/B.t. product mixture is incorporated into an agar-based wheat germ casein diet. The insects are placed on the diet for four days and held at 28"C. Mortality is recorded and analyzed using probit analysis. LC 50 , LC 90 and potency are calculated from matched product lacking la. The results shown in Table V indicate that la potentiate various B.t.k. and B.t.a. products obtained from various sources. The B.t. strains contained in these products are described in Section 5.2., εupra . TABLE V Potentiation of B.t. Products on Spodoptera exigua q la per BIU Increase in activity Product Fold reduction in C^n BACTOSPEINE™ WP 0.4 1.04 1.7 2.3 CONDOR™ 0.4 2.4 1.7 5.1 AGREE™ 0.4 1.1 1.7 1.6 CUTLASS™ 0.4 1. 1 1.7 2.5 MVP™ 0.4 6, 0 1.7 7 7 2.0 12 1 FLORBAC™ HPWP 0.2 1.1 0.8 2.0 DIPEL™ 2X 0.2 1.2 0.8 2.3 2.0 3.9 JAVELIN™ WG 0.2 0 0.8 1.08 2.0 2.9 XENTARI™ 0.2 1.2 0.8 1.6 2.0 2.4 7.7. F LTAR BIOASSAYS Foliar bioassays are performed with second instar Spodoptera exigua larvae on broccoli plants using BIOBIT™ FC and la. The ratio of la to BIOBIT™ FC is the same 2 g Ia/BIU BIOBIT™ FC. The treatments are applied to broccoli plants via a track sprayer in a carrier volume of 20 gallons per acre. Leaves are excised from the plants after the spray deposit had dried, and infested with second instar Spodoptera exigua larvae. The results are shown in Table VI, infra . 100% mortality is observed at a rate of 8.7 BlU/hectare BIOBIT™ FC + la, while BIOBIT™ FC alone killed 92% of the larvae at 58.8 BlU/hectare and 8% at 17.6 BlU/hectare. Treated plants are also placed in direct sunlight for eight hours, after which leaves are excised and infested. After eight hours in sunlight, BIOBIT™ FC alone at 58.8 BlU/hectare gave 27% mortality, while BIOBIT™ FC + la gave 100% mortality at 8.7 BlU/hectare. A foliar assay done with early fourth instar larvae had BIOBIT™ FC alone with 75% mortality at 52 BlU/hectare, and BIOBIT™ FC (FC is flowable concentrate) + la gave 100% mortality at 13 BlU/hectare. TABLE VI Foliar Bioassavs Treatment BlU/hectare % mortality larval instar BIOBIT™ FC 58.8 92% 2 BIOBIT™ FC 17.6 8% 2 BIOBIT™ FC + la 8.7 100% 2 BIOBIT™ FC + 8hr sunlight 58.8 27% 2 BIOBIT™ FC + la + 8hr sunlight 8.7 100% 2 BIOBIT™ FC 52 75% 4 BIOBIT™ FC + la 13 100% 4 7.8. FIELD TRIALS Field trials on garbonzo beans (Spodoptera exigua) demonstrated that BIOBIT™ FC alone at 70 BlU/hectare gave 51% control while 2 g Ia/BIU BIOBIT™ FC at 40 BlU/hectare provided 89% control (relative to no treatment) . JAVELIN™ WG at 45 BlU/hectare gave 51% control. Field trials on sweet corn (Spodoptera frugiperda) demonstrated that at 39.5 BlU/hectare, 2 g Ia/BIU BIOBIT™ FC provided 84% control. 7.9. RESISTANCE RATIOS Colonies of susceptible and resistant Plutella xyloεtella are bioassayed. Resistant moths are field collected samples from Florida that have developed B.t. resistance following intensive exposure to JAVELIN™ WG. BIOBIT™ HPWP with la is analyzed using a leaf-dip bioassay. Resistance to JAVELIN™ and XENTARI™ is assayed without la. Six cm diameter cabbage leaf disks are dipped for 10 seconds into one of eight different concentrations of B.t. products or B.t./la formulations. Concentrations range from 1 to 1000 ppm. The leaf disks are allowed to air dry for two hours and placed in plastic petri dishes with second instar (0.2 to 0.4 mg) larvae. Twenty five insects/dose/day are replicated twice to give 50 insects/dose. After 72 hours at 27'C, mortality is recorded. Dose mortality regression is analyzed with probit analysis. Resistance ratios are calculated by dividing the LC 50 and LC 90 values of the susceptible moths. The results are shown in Table VII and indicate that the BIOBIT™ HPWP potentiates with 2 g Ia/BIU and 4 g Ia/BIU. Specifically, with 4 g Ia/BIU there is a 2 fold decrease in the LC 5 0 resistance ratio and a 10 fold decrease in the LC 90 resistance ratio. TABLE VII Plutella xyloεtella (B.t.k. Resistant) Resistance Ratios LC50 RR LC90 RR PRODUCT TESTED JAVELIN™ WG 302.6 3829.7 BIOBIT™ HPWP 20.5 98.5 23.2 88.0 2.0 g Ia/BIU BIOBIT™ HPWP 4.0 g Ia/BIU 10.4 11.5 BIOBIT™ HPWP XENTARI™ 9.7 8.2 7.10. Mutants 7.10.1.Strain The strains Bacilluε thuringienεiε subsp. kurεtaki EMCC0086 (NRRL B-21147), Septoria nodorum (A04119), and Alternaria alternata (strain 6, IM-SMP) are used. 7.10.2. Funσal Growth Inhibition Assay Mutants of the Bacillus thuringienεiε subsp. kurεtaki strain which produce the factor are identified using fungal agar plates of Septoria nodorum and Alternaria alternata. The factor inhibits growth of both fungi. The two fungi are grown on PDA (potato dextrose agar) plates at 26°C for 10-14 days until sufficient sporulation is obtained. Alternaria alternata is incubated in alternating UV light and darkness (12 hrs. each). The spores are removed from the plates and suspended in sterile water. Septoria nodorum spores are filtered through a sterile Gl filter. The Alternaria alternata spore concentration is adjusted to approximately 2 x 10 5 per ml and the Septoria nodorum spore concentration is adjusted to approximately 2 x 10 6 per ml using a Burker-Turk or Fuchs-Rosenthal counter. Samples of 1.5 ml of the spore suspension are then mixed with 1.5 ml of sterile 40% glycerol in water, frozen for 1 day at -20°C and thereafter stored at -80°C until use. Test plates for the factor are prepared by mixing at 46°C a 1.5 ml spore sample (as described above) with 115 ml of antibiotic agar medium No. 2 (25.5 g per liter) comprising streptomycin at a final concentration of 100 μg per ml, and transferring the mixture to sterile plastic trays (Nunc No. 101875) . After the agar has solidified, mm holes are punched into the agar (120 holes per tray) . Samples of a culture are serially diluted in 100 μg of streptomycn per ml of sterile water and 10 μl of the diluted samples are dispensed into the trays prepared as described above. The trays are incubated at 26°C for 2 days. Dilutions of the factor are also run as a positive control. The sensitivity of the fungal growth inhibition assay is in the range of 0.05 gram of the factor per liter (barely visible) and 0.1 gram of the factor per liter (clear zone) for both fungi. 7.10.3. Capillary Zone Electrophoresis Measurement of Factor Cells and other insolubles are removed from a whole culture broth sample by centrifugation and/or by filtration through a 0.2 μm Nylon membrane filter prior to analysis. A Beckman P/ACE Capillary Electrophoresis System equipped with a 50 μm x 47 cm uncoated capillary, running buffer consisting of 0.1 M phosphate pH 6.6, voltage at 15 KV, and detection at 200 nm is used for quantification of the factor. Before each run, the capillary is flushed with the running buffer for 2 minutes. The volume of the sample loaded is 20 nl. The run time for analysis is 12 minutes with the factor eluting at approximately 8.5 minutes. The concentration of the factor is determined relative to a standard curve of the pure compound. Between each 12 minute run, the capillary is flushed sequentially with 1 N sodium hydroxide for 0.5 minute, 0.1 N sodium hydroxide for 0.5 minute, HPLC water for 0.5 minute, and 1.5 M phosphoric acid for 0.5 minute. 7.10.4. Mutaσenesis of B. thuringiensis subsp. kurstaki Strain Spores of the Bacillus thuringienεiε subsp. kurεtaki NB75 strain are treated first with gamma-rays at 700 Krads. The irradiated spores are serially diluted, spread onto TY agar plates, and incubated at 30°C for 2 days. Eighty mutants from the treatment are purified by single colony streaking on TY agar plates and are then transferred to 500 ml shake flasks containing 100 ml of medium with the following composition: Corn Steep Liquor 15 g/liter Maltodextrin 40 g/liter Potato Protein 30 g/liter KH 2 P0 1.77 g/liter K 2 HP0 4 4.53 g/liter The shake flasks are incubated at 30°C, 250 rpm for 3 days. Samples of 5 ml are taken daily from each of the shake flask cultures and centrifuged to pellet the cells. The supernatants are diluted 2-10 times in streptomycin at a concentration of 0.1 mg per ml of deionized water and then are tested for antifungal activity as described in Section 8.2. Culture samples of those mutants producing the greatest inhibition of fungal growth are then analyzed for the amount of the factor by capillary zone electrophoresis as described in Section 8.3. The highest producing mutant from the first mutation is NBB-76. The first generation mutant NBB-76 is then subjected to a second mutation using N,N' -dinitro-N' -nitrosoguanidine (NTG) . Specifically, the mutant strain is cultivated overnight at 30°C, 240 rpm in a 500 ml shake flask containing 100 ml of TY broth with the following composition adjusted to pH 7.3 before autoclaving: Tryptone 20 g/liter Yeast extract 5 g/liter FeCl 2 -4H 2 0 6 mg/liter MnCl 2 -4H 2 0 1 mg/liter MgS0 4 -7H 2 0 15 mg/liter The overnight culture is diluted 100 times into a new shake flask containing TY medium and cultivated at 30°C, 240 rpm until the culture reaches logarithmic growth (approximately 4 hours) . A sample of 10 ml of the culture is removed from the shake flask and then germfiltrated using a 0.45 μm Nalgene filter unit. The cells on the filter are resuspended in 10 ml of TM buffer containing 100 μg of NTG per ml. TM buffer is comprised of 6.05 g of Tris and 5.08 g of maleic acid per liter of deionized water adjusted to pH 6 with sodium hydroxide. The suspended cells are incubated at 37°C for 30 minutes and then are connected to a vacuum source to remove the NTG from the cells. The cells are washed two times with 20 ml of M9 buffer before they are resuspended in 10 ml of M9 buffer, serially diluted, spread onto TY agar plates, and incubated at 30°C for 2 days. M9 buffer is comprised of 8.78 g of Na 2 HP0 -2H 2 0, 3 g of KH 2 P0 4 , 4 g of NaCl, and 0.2 g of MgS0 4 -7H 2 0 per liter of deionized water. Mutants are isolated and tested as described above. The highest producing mutant obtained from the second round of mutation is EMCC0130. The second generation mutant EMCC0130 is then subjected to a third mutation using NTG as described above. The highest producing mutant obtained from the third round of mutation is NBC-217. The third generation mutant NBC-217 is then subjected to a fourth mutation using NTG as described above. The highest producing mutant obtained from the fourth round of mutation is EMCC0129. 7.10.5. Factor Production by Mutants and Parent Strain Mutants EMCC0130, NBC-217, and EMCC0129 and the parent strain Bacilluε thuringienεiε subsp. kurεtaki EMCC0086 are grown in 250 ml shake flasks containing 50 ml of medium comprised of the following components supplemented with trace metals at 0.2 ml per liter and then adjusted to pH 7 with H 3 P0 4 prior to sterilization: Hydrolyzed Vegetable Protein 30 g/liter Hydrolyzed Starch 40 g/liter K 2 HP0 4 5 g/liter MgS0 4 0.3 g/liter The shake flask cultures are incubated at 30°C, 250 rpm for 3 days. Quantitative analysis of the factor produced by the mutants and the parent strain is performed by capillary zone electrophoresis as described in Section 8.3. Quantitative analysis indicates that mutant EMCC0129 produces approximately 0.9 g of the factor per liter of culture broth after 3 days in shake flasks while the parent strain produces approximately 0.15 g per liter. Mutant EMCC0129 produces approximately 6-fold more factor than the parent strain. Table VIII: Production of Factor by Mutants of Bacillus thuringienεiε subsp. kurstaki Mutant Factor (σ/liter) Parent 0.15 EMCC0130 0.65 NBC-217 0.65 EMCC0129 0.75 The invention described and claimed herein is not to be limited in scope by the specific embodiments herein disclosed, since these embodiments are intended as illustrations of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. Various references are cited herein, the disclosures of which are incorporated by reference in their entireties. 8. DEPOSIT OF MICROORGANISMS The following strains of Bacillus thuringiensis have been deposited according to the Budapest Treaty in the Agricultural Research Service Patent Culture Collection (NRRL) , Northern Regional Research Center, 1815 University Street, Peoria, Illinois, 61604, USA. Strain Accession Number Deposit Date EMCC0086 NRRL B-21147 October 6, 1993 EMCC0129 NRRL B-21445 May 23, 1995 EMCC0130 NRRL B-21444 May 23, 1995 The strains have been deposited under conditions that assure that access to the culture will be available during the pendency of this patent application to one determined by the Commissioner of Patents and Trademarks to be entitled thereto under 37 C.F.R. §1.14 and 35 U.S.C. §122. The deposit represents a substantially pure culture of each deposited strain. The deposit is available as required by foreign patent laws in countries wherein counterparts of the subject application, or its progeny are filed. However, it should be understood that the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by governmental action.

Claims: WHAT IS CLAIMED IS 1. A mutant of a Bacillus strain which produces a factor which potentiates the pesticidal activity of a Bacilluε related pesticide, wherein the amount of the factor produced by the mutant is greater than the amount of the factor produced by a corresponding parental strain, wherein said Bacilluε strain is selected from the group consisting of Bacilluε licheniformis. Bacillus εubtiluε, and Bacilluε thuringiensis . 2 . The mutant according to claim 1, wherein the mutant produces at least about 2 times more factor than the corresponding parental strain. 3. The mutant according to claim 1, wherein the factor has IH NMR shifts at about δl.5, 3.22, 3.29, 3.35, 3.43, 3.58, 3.73, 3.98, 4.07, 4.15, 4.25, and 4.35, and "C shifts at about 31.6, 37.2, 51.1, 53.3, 54.0, 54.4, 61.5, 61.6, 64.1, 65.6, 158.3, 170.7, and 171.3. 4. The mutant according to claim 1, wherein the factor has the structure I or salt thereof 5. The mutant according to claim 1, wherein the Bacilluε strain is a Bacilluε thuringiensis strain. 6. The mutant according to claim 5, wherein the Bacillus thuringienεiε strain is selected from the group consisting of strains of Bacillus thuringiensis subsp. aizawai , Bacillus thuringiensis subsp. alesti , Bacillus thuringiensis subsp. canadiensiε, Bacillus thuringiensis subsp. colmeri , Bacilluε thuringiensis subsp. coreanensis, Bacillus thuringiensis subsp. dakota , Bacillus thuringiensis subsp. darmstadienεiε, Bacilluε thuringienεiε subsp. dendrolimuε, Bacilluε thuringiensis subsp. entomociduε, Bacilluε thuringiensis subsp. finitimuε, Bacilluε thuringiensis subsp. galleriae, Bacillus thuringienεiε subsp. Indiana, Bacilluε thuringienεiε subsp. israelensiε, Bacilluε thuringienεiε subsp. kenyae, Bacillus thuringienεiε subsp. kumamotoenεiε , Bacillus thuringienεiε subsp. kurεtaki , Bacillus thuringienεiε subsp. kyuεhuenεiε, Bacilluε thuringienεiε subsp. japonensis, Bacilluε thuringienεiε subsp. mexcanenεiε, Bacillus thuringiensis subsp. morrisoni , Bacilluε thuringienεiε subsp. neoleonenεis , Bacilluε thuringienεiε subsp. nigeriae, Bacilluε thuringiensis subsp. ostriniae, Bacilluε thuringienεiε subsp. pakiεtani , Bacilluε thuringienεiε subsp. pondicherienεiε , Bacilluε thuringiensis subsp. Shandong ienεis , Bacillus thuringienεiε subsp. εilo , Bacilluε thuringienεiε subsp. sotto, Bacilluε thuringiensis subsp. εubtoxicuε, Bacilluε thuringienεiε subsp. tenebrioniε, Bacilluε thuringiensis subsp. thompεoni , Bacilluε thuringienεiε subsp. tochigienεiε, Bacillus thuringiensis subsp. tohokuensiε, Bacilluε thuringienεiε subsp. tolworthi , Bacilluε thuringiensis subsp. toumanoffi , Bacillus thuringiensis subsp. wuhanensiε, and Bacilluε thuringienεiε subsp. yunnanenεiε. 7. The mutant according to claim 5, wherein the Bacilluε thuringienεiε strain is a Bacilluε thuringiensis subsp. kurs aki s rain. 8. The mutant according to claim 1, wherein the mutant has the identifying characteristics of EMCC0129, deposited with the NRRL, having an accession number of NRRL B- wwww; or has the identifying characteristics of EMCC0130, deposited with the NRRL, having an accession number of NRRL B- xxxx. 9. The mutant according to claim 1, wherein the Bacilluε related pesticide comprises a Bacilluε thuringienεiε delta-endotoxin or a pesticidally-active fragment thereof. 10. The mutant according to claim 9, wherein the Bacilluε thuringienεiε delta-endotoxin or the pesticidally- active fragment thereof is selected from the group consisting of Cryl, Cryll, CryIII, CryIV, CryV, and CryVI. 11. The mutant according to claim 10, wherein the Bacilluε thuringienεiε delta-endotoxin or the pesticidally- active fragment thereof is a CrylA delta-endotoxin or a pesticidally-active fragment thereof. 12. The mutant according to claim 10, wherein the Bacilluε thuringi enεiε delta-endotoxin or the pesticidally- active fragment thereof is a CrylC delta-endotoxin or a pesticidally-active fragment thereof. 13. The mutant according to claim 1, wherein the Bacilluε related pesticide comprises a Bacilluε thuringiensis spore. 14. The mutant according to claim 1, wherein the factor is obtained by (a) culturing the mutant of the Bacillus strain under suitable conditions; (b) recovering a supernatant of the culture of the mutant of step (a) ,- and (c) isolating the factor from the supernatant of step (b) . 15. The mutant according to claim 14, wherein the factor is obtained from the supernatant of the culture of a Bacillus thuringienεiε strain. 16. A method for obtaining the mutant of claim 1 comprising (a) treating a Bacilluε strain with a mutagen; (b) growing the mutated Bacilluε strain of step (a) under suitable conditions for selecting the mutant; and (c) selecting the mutant of step (b) . 17. A mutant of a Bacilluε strain obtained according to the method of claim 16.

Inventors: LIDSTER WILLIAM D, MACINTOSH SUSAN C, MANKER DENISE, OUTTRUP HELLE, STARNES ROBERT L, LIDSTER, WILLIAM, D., MACINTOSH, SUSAN, C., MANKER, DENISE, OUTTRUP, HELLE, STARNES, ROBERT, L.
Applicants: ABBOTT LAB, ABBOTT LABORATORIES
Application year: 1996
Main classification: C12N1
IPC codes: A01N25, A01N47, A01N63, C12N1, C12N15, C12P13, C12R1